New Life Medical Services Stem Cell Investigation

Written by 
Published on:
November 18, 2026
Updated on:
November 18, 2026

Many clinics across the country now sell injections made from umbilical cord tissue, amniotic fluid, and exosomes, and they often promote these products as ways to repair damaged tissue or ease chronic pain. Federal law treats many of these products as drugs and biologics, which means a seller generally needs FDA approval before bringing them to market, and very few of these products have that approval.

Contact the stem cell fraud lawyers at The Lyon Firm to learn more about current cases and investigations.

What the FDA Said in the New Life Medical Letter

On September 24, 2025, the FDA’s Center for Biologics Evaluation and Research sent a warning letter to New Life Medical Services, LLC, a company based in Lutz, Florida, following an inspection of its facility in May 2024.

According to the letter, the company sells products named Restor+, Regain, Renyte, ReCyte, and Rexo, and the FDA concluded that all of them are unapproved new drugs and unlicensed biological products.

The agency also found that the cord-derived products involved more than minimal processing and were intended for uses beyond those the umbilical cord performs in the body, which keeps them from qualifying for a lighter regulatory category.

The letter does not amount to a court ruling, and it gave the company the chance to respond and explain why it disagrees. This article summarizes statements made in a public FDA letter and makes no finding that any company or individual violated the law.

The Marketing Claims at Issue

The FDA reviewed New Life Medical Service's website, physician guides, training videos, and Instagram page, and it explained that the language in these materials showed the products were meant to treat disease or change how the body functions. The letter cited examples such as:

  • Statements that a product supports tissue repair and regeneration
  • Descriptions of anti-inflammatory effects
  • Training videos showing use for neuropathy, bone spurs, and pain
  • A social media post listing orthopedic, hair restoration, and neuropathy applications

The letter also pointed the company to an FDA safety notification on exosome products, which the agency issued after receiving reports of serious adverse events in patients.

Why Hire The Lyon Firm

Patients usually pay for these injections out of pocket, and many make that choice because a provider described the product as a proven way to heal or relieve pain. Depending on the facts, state consumer protection laws may give patients a path to recover money when a seller or provider misrepresents what a treatment can do, and the outcome of any claim depends on what was promised.

Deceptive medical marketing cases require careful fact gathering and a working knowledge of FDA rules, and The Lyon Firm offers both.

If you received a New Life Medical Services product or paid for a treatment at a different clinic, call The Lyon Firm at (513) 381-2333 and an attorney will review your situation and explain your options.

Contact Us

Request a Free Consultation

Taking the first step doesn’t have to be complicated. In just a few minutes, you can share the basics of your case, and our team will guide you from there:

  • It begins with a few simple questions about your situation.
  • From there, a member of our legal team reviews your case.
  • Together, we’ll chart the path forward, helping you take the next step toward resolution.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.